Cullen, Valerie
NeuroPhage Pharmaceuticals, Inc. Cambridge MA USA
2 papers on CoChat
Most cited papers
- Verified
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Mollenhauer, B., Cullen, V., Kahn, I., Krastins, B., Outeiro, T. F., Pepivani, I., Ng, J., Schulz-Schaeffer, W., Kretzschmar, H. A., McLean, P. J., et al. (2008) · Experimental Neurology
Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments
Cited by 382
- Verified
NPT088 reduces both amyloid‐β and tau pathologies in transgenic mice
Levenson, J. M., Schroeter, S., Carroll, J. C., Cullen, V., Asp, E., Proschitsky, M., Chung, C. H. ‐., Gilead, S., Nadeem, M., Dodiya, H. B., et al. (2016) · Alzheimer's & Dementia: Translational Research & Clinical Interventions
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 47
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free